share_log

Illumina | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Illumina | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Illumina | S-3ASR：“知名成熟发行人”证券注册声明
美股SEC公告 ·  09/04 09:05
Moomoo AI 已提取核心信息
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, has filed a registration statement with the Securities and Exchange Commission (SEC) on September 4, 2024, for the issuance of various securities, including debt securities, common stock, preferred stock, warrants, stock purchase contracts, stock purchase units, and subscription rights. The registration allows Illumina to offer these securities to the public from time to time, providing the company with financial flexibility for future corporate activities. The securities may be sold through underwriters, dealers, agents, or directly to investors, and the terms will be determined at the time of each offering and detailed in future prospectus supplements. Illumina's common stock is listed on the Nasdaq Global Select Market under the symbol 'ILMN.'
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, has filed a registration statement with the Securities and Exchange Commission (SEC) on September 4, 2024, for the issuance of various securities, including debt securities, common stock, preferred stock, warrants, stock purchase contracts, stock purchase units, and subscription rights. The registration allows Illumina to offer these securities to the public from time to time, providing the company with financial flexibility for future corporate activities. The securities may be sold through underwriters, dealers, agents, or directly to investors, and the terms will be determined at the time of each offering and detailed in future prospectus supplements. Illumina's common stock is listed on the Nasdaq Global Select Market under the symbol 'ILMN.'
Illumina公司，全球领先的DNA测序和基于阵列的技术公司，于2024年9月4日向美国证券交易委员会（SEC）提交了一份注册声明，以发行各种证券，包括债券、普通股、优先股、认股权证、股票购买合同、股票购买单位和认购权。注册使Illumina可以不时向公众提供这些证券，为公司未来的企业活动提供财务灵活性。这些证券可以通过承销商、经销商、代理人直接销售给投资者，并且每次发行时的条款将在将来的注册声明补充中详细说明。Illumina的普通股在纳斯达克全球精选市场上以“ILMN”标的上市。
Illumina公司，全球领先的DNA测序和基于阵列的技术公司，于2024年9月4日向美国证券交易委员会（SEC）提交了一份注册声明，以发行各种证券，包括债券、普通股、优先股、认股权证、股票购买合同、股票购买单位和认购权。注册使Illumina可以不时向公众提供这些证券，为公司未来的企业活动提供财务灵活性。这些证券可以通过承销商、经销商、代理人直接销售给投资者，并且每次发行时的条款将在将来的注册声明补充中详细说明。Illumina的普通股在纳斯达克全球精选市场上以“ILMN”标的上市。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

独立文件5  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息